VRDN - Viridian Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRDN is currently covered by 12 analysts with an average price target of $37.3. This is a potential upside of $17.47 (88.1%) from yesterday's end of day stock price of $19.83.

Viridian Therapeutics's activity chart (see below) currently has 17 price targets and 81 ratings on display. The stock rating distribution of VRDN is 96.97% BUY and 3.03% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.48% with an average time for these price targets to be met of 124.31 days.

Highest price target for VRDN is $47, Lowest price target is $20, average price target is $37.3.

Most recent stock forecast was given by TIAGO FAUTH from CREDIT SUISSE on 19-Dec-2024. First documented stock forecast 20-Jan-2021.

Currently out of the existing stock ratings of VRDN, 64 are a BUY (96.97%), 2 are a HOLD (3.03%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$27

$7.97 (41.88%)

$51

7 days ago
(19-Dec-2024)

0/4 (0%)

$8.61 (46.82%)

Buy

$34

$14.97 (78.67%)

$34

9 days ago
(17-Dec-2024)

1/15 (6.67%)

$13.41 (65.13%)

40

Buy

$47

$27.97 (146.98%)

$44

9 days ago
(17-Dec-2024)

0/11 (0%)

$26.41 (128.27%)

Buy

$38

$18.97 (99.68%)

$38

1 months 1 days ago
(25-Nov-2024)

0/13 (0%)

$17.04 (81.30%)

Buy

$28

$8.97 (47.14%)

$31

4 months 14 days ago
(12-Aug-2024)

0/6 (0%)

$12.71 (83.13%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRDN (Viridian Therapeutics) average time for price targets to be met?

On average it took 124.31 days on average for the stock forecasts to be realized with a an average price target met ratio 13.48

Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on VRDN

Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?

Maneka Mirchandaney with highest potential upside - $35.97

Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?

Michael Higgins with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?